Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine
Crossref DOI link: https://doi.org/10.1007/s10495-017-1364-4
Published Online: 2017-03-17
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cosenza, Maria
Civallero, Monica
Marcheselli, Luigi
Sacchi, Stefano
Pozzi, Samantha
License valid from 2017-03-17